Company news

Poxel SA news in 2025

Poxel SA's news releases, calls and decks from 2025, newest first.

View company

Availability of Poxel’s 2025 Half-Year Financial Report

December 18, 2025

Poxel Announces Results of its Combined General Meeting Held on December 11, 2025

December 11, 2025

Poxel Publishes Its Financial Results for the First Half of 2025

December 10, 2025

POXEL SA: Update on the Proposed Recovery Plan and Organisation of a Webinar

November 24, 2025

Poxel Announces That a Combined General Meeting Will Be Held on December 11, 2025 and the Availability of the Preparatory Documents

November 20, 2025

Poxel Reports Revenue for the Third Quarter 2025

November 13, 2025

POXEL SA: Update on the Draft Recovery Plan and Convening of the Annual General Meeting of Shareholders

November 5, 2025

Appointment of Yves Decadt as Member of Poxel’s Board of Directors

October 31, 2025

Poxel: Availability of the 2024 Universal Registration Document

October 23, 2025

Poxel: Availability of a First Document in Response to Questions Received From Shareholders

October 20, 2025

Poxel Reports Financial Results for Full Year 2024 and Provides Operational and Financial Update

October 16, 2025

Poxel Announces the Availability of a Bond Issue for a Maximum Amount of €2.5 Million

September 29, 2025

Poxel Announces the Opening of Reorganization Proceedings

August 8, 2025

Following the Filing for the Opening of Reorganization Proceedings, Poxel Announces Changes to Its Corporate Governance

August 1, 2025

Poxel Provides Update on Negotiations with Creditors and Announces Filing of Reorganization Proceedings, Upcoming Change of Corporate Governance and Suspension of Trading

July 29, 2025

Poxel Announces Postponement of its Annual General Meeting and Provides a Corporate Update

June 30, 2025

Poxel SA: New Scientific Presentations by Key Opinion Leaders to Further Highlight the Therapeutic Potential of Imeglimin at ADA 2025, the Leading Diabetes Conference

June 19, 2025

New Clinical and Scientific Data on TWYMEEG® to be Presented at the 68th Annual Meeting of the Japan Diabetes Society

May 28, 2025

Poxel Announces Positive Preclinical Data for PXL065 in Hypertrophic Cardiomyopathy To Be Presented at the ESC Congress 2025

May 26, 2025

Poxel Reports Consolidated Revenue for the First Quarter 2025 and Provides Corporate Update

May 13, 2025

Decks in 2025